TrialToxins2022

Incobotulinum Toxin Type A for Treatment of Ultraviolet-B-Induced Hyperpigmentation: A Prospective, Randomized, Controlled Trial.

Vasanop Vachiramon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.